• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Treatment-resistant depression: recent developments and future directions.
Depress Anxiety. 2008;25(12):989-92. doi: 10.1002/da.20540.
2
Treatment options for the patient who does not respond well to initial antidepressant therapy.对初始抗抑郁治疗反应不佳的患者的治疗选择。
J Psychiatr Pract. 2009 May;15(3):202-10. doi: 10.1097/01.pra.0000351880.30013.2a.
3
Aripiprazole in refractory depression?阿立哌唑治疗难治性抑郁症？
J Clin Psychopharmacol. 2009 Feb;29(1):90-1; author reply 92-3. doi: 10.1097/JCP.0b013e318193c9b1.
4
Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.阿立哌唑辅助治疗重度抑郁症研究结果的临床意义不明确：对马库斯等人文章的评论
J Clin Psychopharmacol. 2009 Feb;29(1):91-2; author reply 92-3. doi: 10.1097/JCP.0b013e318194087c.
5
Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.阿立哌唑增强反苯环丙胺治疗难治性重度抑郁症的疗效。
J Clin Psychopharmacol. 2007 Apr;27(2):216-7. doi: 10.1097/01.jcp.0000264970.54711.43.
6
Aripiprazole adjunctive to antidepressant therapy.
Am J Psychiatry. 2011 Feb;168(2):211; author reply 211. doi: 10.1176/appi.ajp.2010.10101515.
7
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.阿立哌唑辅助治疗重度抑郁症：对伴有焦虑和非典型特征患者的疗效与安全性分析
J Clin Psychiatry. 2008 Dec;69(12):1928-36. Epub 2008 Dec 2.
8
Treatment-resistant depression in Hispanic patients. Hispanic 患者的治疗抵抗性抑郁症。
J Clin Psychiatry. 2010 Jun;71(6):e12. doi: 10.4088/JCP.8153tx3cc.
9
Successful ECT treatment after relapse during VNS therapy.电休克治疗在迷走神经刺激治疗期间复发后的成功治疗。
Psychiatr Danub. 2010 Nov;22 Suppl 1:S166.
10
Aripiprazole as an adjunctive treatment for refractory major depression.阿立哌唑作为难治性重度抑郁症的辅助治疗药物。
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1347-8. doi: 10.1016/j.pnpbp.2004.06.016.

引用本文的文献

1
Inflamed brain: Targeting immune changes and inflammation for treatment of depression.炎症性大脑：针对免疫变化和炎症治疗抑郁症。
Psychiatry Clin Neurosci. 2021 Oct;75(10):304-311. doi: 10.1111/pcn.13286. Epub 2021 Jul 28.
2
Accelerated TMS for Depression: A systematic review and meta-analysis.加速经颅磁刺激治疗抑郁症：系统评价和荟萃分析。
Psychiatry Res. 2019 Mar;273:770-781. doi: 10.1016/j.psychres.2018.12.041. Epub 2018 Dec 7.
3
Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.在真实世界数据中寻找治疗抵抗性抑郁症：数据驱动方法与基于专家启发式的方法比较。
Depress Anxiety. 2018 Mar;35(3):220-228. doi: 10.1002/da.22705. Epub 2017 Dec 15.
4
Effects of electroconvulsive therapy on cognitive functioning in patients with depression: protocol for a systematic review and meta-analysis.电休克治疗对抑郁症患者认知功能的影响：一项系统评价和荟萃分析的方案
BMJ Open. 2015 Mar 11;5(3):e006966. doi: 10.1136/bmjopen-2014-006966.
5
GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.GSK-3 抑制增强了亚阈值剂量氯胺酮的促突触生成和抗抑郁样作用。
Neuropsychopharmacology. 2013 Oct;38(11):2268-77. doi: 10.1038/npp.2013.128. Epub 2013 May 17.
6
Depression as a risk factor for adverse outcomes in coronary heart disease.抑郁作为冠心病不良结局的一个危险因素。
BMC Med. 2013 May 15;11:131. doi: 10.1186/1741-7015-11-131.
7
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.重复氯胺酮输注治疗难治性重度抑郁症的快速和长期抗抑郁作用。
Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27.
8
Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?氯胺酮带来的快速抗抑郁反应：它是难治性抑郁症的解决方案吗？
Indian J Psychol Med. 2012 Jan;34(1):56-60. doi: 10.4103/0253-7176.96161.
9
Ketamine for treatment-resistant unipolar depression: current evidence.氯胺酮治疗抵抗性单相抑郁：当前证据。
CNS Drugs. 2012 Mar 1;26(3):189-204. doi: 10.2165/11599770-000000000-00000.
10
Identification and management of cryptic bipolarity in patients with TRD.
J Psychiatry Neurosci. 2011 Mar;36(2):E3-4. doi: 10.1503/jpn.100135.

本文引用的文献

1
Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.前扣带回皮质对恐惧面孔反应增强：一种预测对氯胺酮快速抗抑郁反应的神经生理生物标志物。
Biol Psychiatry. 2009 Feb 15;65(4):289-95. doi: 10.1016/j.biopsych.2008.08.014. Epub 2008 Sep 25.
2
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.在第二步抗抑郁药物单一疗法中进行选择：临床、人口统计学或第一步治疗特征的预测价值。
Arch Gen Psychiatry. 2008 Aug;65(8):870-80. doi: 10.1001/archpsyc.65.8.870.
3
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression.扣带回下区深部脑刺激治疗难治性抑郁症。
Biol Psychiatry. 2008 Sep 15;64(6):461-7. doi: 10.1016/j.biopsych.2008.05.034. Epub 2008 Jul 18.
4
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.抗抑郁反应啮齿动物模型中相关基因的药物遗传学分析：STAR(*)D研究中TREK1与治疗抵抗的关联
Neuropsychopharmacology. 2008 Nov;33(12):2810-9. doi: 10.1038/npp.2008.6. Epub 2008 Feb 20.
5
Medication effects in neuroimaging studies of bipolar disorder.双相情感障碍神经影像学研究中的药物效应。
Am J Psychiatry. 2008 Mar;165(3):313-20. doi: 10.1176/appi.ajp.2007.07071066. Epub 2008 Feb 1.
6
Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression.用于治疗难治性抑郁症的脑深部刺激所针对的膝下扣带回区域的解剖学连接性。
Cereb Cortex. 2008 Jun;18(6):1374-83. doi: 10.1093/cercor/bhm167. Epub 2007 Oct 10.
7
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.重度抑郁症治疗抵抗相关的临床因素：一项欧洲多中心研究的结果
J Clin Psychiatry. 2007 Jul;68(7):1062-70. doi: 10.4088/jcp.v68n0713.
8
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.阿立哌唑作为重度抑郁症辅助治疗的疗效与安全性：一项多中心、随机、双盲、安慰剂对照研究
J Clin Psychiatry. 2007 Jun;68(6):843-53. doi: 10.4088/jcp.v68n0604.
9
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.经颅磁刺激在重度抑郁症急性治疗中的疗效与安全性：一项多中心随机对照试验
Biol Psychiatry. 2007 Dec 1;62(11):1208-16. doi: 10.1016/j.biopsych.2007.01.018. Epub 2007 Jun 14.
10
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.在对照试验和临床实践中最大化药物治疗的充分性：STAR(*)D基于测量的照护
Neuropsychopharmacology. 2007 Dec;32(12):2479-89. doi: 10.1038/sj.npp.1301390. Epub 2007 Apr 4.

Treatment-resistant depression: recent developments and future directions.

作者信息

Mathew Sanjay J

机构信息

Mood and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA.

出版信息

Depress Anxiety. 2008;25(12):989-92. doi: 10.1002/da.20540.

DOI:10.1002/da.20540
PMID:19058261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2933841/
Abstract
摘要